Bruker acquires Chemspeed

Since its founding in 2004, Chemspeed has been offering a portfolio of flexible automation modules, ranging from bench-top workstations to integrated automated R&D workflows, which can transform R&D productivity in industries such as pharmaceuticals, biotech, chemicals, cleantech, materials, cosmetics and food. Chemspeed automation is used every day in top R&D and QC laboratories globally, setting standards in lab automation. Chemspeed also offers compliance-ready workflow solutions to automate and digitalize R&D and QC in regulated environments, ensuring data integrity, traceability and quality.

Bruker Corporation, the provider of high-performance scientific instruments and high-value analytical and diagnostic solutions enabling scientists to explore life and materials at molecular, cellular and microscopic levels, has entered a definitive agreement to acquire Chemspeed. The acquisition aims to accelerate its entry into lab automation, digitalization and scientific software solutions. Chemspeed complements Bruker’s vendor-agnostic platform SciY for software automation and digital transformation of R&D labs in the life science, biopharma and cleantech industries. Strategically, Chemspeed’s automation solutions strengthen Bruker’s Project Accelerate 2.0 initiative ‘Assays, Software and Aftermarket’. 

The closing of the transaction is expected to occur in the first half of 2024, subject to regulatory reviews. Financial details of the transaction were not disclosed. In 2023, Chemspeed generated revenues greater than $50 million, and Chemspeed was profitable.

Dr Rolf Gueller, Chemspeed's founder and CEO, is excited to join the Bruker family along with his team. He sees the acquisition as an opportunity to further enhance automated and digitalized workflows for the company's customers. 

(Press release)